Bisphosphonates as antialveolar macrophage therapy in pulmonary langerhans cell histiocytosis?
- 3 May 2001
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 36 (6) , 641-643
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Pulmonary Langerhans'-Cell HistiocytosisNew England Journal of Medicine, 2000
- Pulmonary Langerhans'-Cell HistiocytosisNew England Journal of Medicine, 2000
- Macrophage Depletion by Albumin Microencapsulated Clodronate: Attenuation of Cytokine Release in Macrophage-Dependent GlomerulonephritisDrug Development and Industrial Pharmacy, 1999
- Pouch Tissue and Angiotensin Peptide GenerationJournal of Molecular and Cellular Cardiology, 1998
- Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including RasJournal of Bone and Mineral Research, 1998
- Transforming Growth Factor β1, in the Presence of Granulocyte/Macrophage Colony-stimulating Factor and Interleukin 4, Induces Differentiation of Human Peripheral Blood Monocytes into Dendritic Langerhans CellsJournal of Experimental Medicine, 1998
- Link between Angiotensin II and TGF-β in the KidneyMineral and Electrolyte Metabolism, 1998
- Regulation of Human Alveolar Macrophage Inflammatory Cytokines by Tyloxapol: A Component of the Synthetic Surfactant ExosurfClinical Immunology and Immunopathology, 1995
- Measurement of Angiotensin-Converting Enzyme Activity in Intact Human Alveolar Macrophages and Effect of SmokingRespiration, 1988
- Bone Scintigraphy in Pulmonary Alveolar Microlithiasis: A Comparative Study of Radioactivity and Density DistributionClinical Nuclear Medicine, 1982